Roggeri DP, Zanon E, Biasoli C, et al. Extended Half-life rFVIII for the Treatment of Hemophilia A: Drugs Consumption and Patients’ Perspective. Farmeconomia. Health Economics and Therapeutic Pathways. 2020;21(1). https://doi.org/10.7175/fe.v21i1.1472